ALNYLAM PHARMACEUTICALS, INC. Quotes Alnylam Pharmaceuticals, Inc. Börse Stuttgart
Equities
DUL
US02043Q1076
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.7 EUR | -2.41% |
|
+0.47% | +34.62% |
| Jul. 15 | Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing | MT |
| Jul. 03 | Jerome Powell did it again |  |
Quotes 5-day view
Delayed Quote Börse Stuttgart| 2024-07-10 | 2024-07-11 | 2024-07-12 | 2024-07-15 | 2024-07-16 | |
|---|---|---|---|---|---|
| Last | 235.3 € | 239.7 € | 240.7 € | 236.4 € | 230.3 € |
| Volume | 0 | 0 | 0 | 0 | 50 |
| Change | +0.43% | +1.87% | +0.42% | -1.79% | -2.41% |
| Opening | 233.70 | 236.10 | 238.90 | 238.00 | 233.7 |
| High | 236.00 | 240.60 | 240.90 | 238.00 | 233.7 |
| Low | 233.70 | 236.10 | 238.60 | 236.40 | 230.3 |
Performance
| 1 week | +0.47% | ||
| Current month | +3.87% | ||
| 1 month | +59.73% | ||
| 3 months | +70.13% | ||
| 6 months | +33.41% | ||
| Current year | +34.62% | ||
| 1 year | +33.11% | ||
| 3 years | +63.71% | ||
| 5 years | +271.06% | ||
| 10 years | +476.02% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
32 404 663 688
Capitalization (USD)
32 404 663 688
Net sales (USD)
1 828 292 000
Free-Float
99.58 %
Free-Float capitalization (EUR)
35 160 022 575
Free-Float capitalization (USD)
32 268 145 878
Average Daily Capital Traded
0%
Highs and lows
1 week
230.30
240.90
1 month
140.35240.90
3 years
112.80240.90
5 years
62.58240.90
10 years
27.97240.90
Indicators
Moving average 5 days
237.28
Moving average 20 days
207.89
Moving average 50 days
166.46
Moving average 100 days
153.36
Price spread / (MMA5)
+2.85%
Price spread / (MMA20)
-9.89%
Price spread / (MMA50)
-27.85%
Price spread / (MMA100)
-33.52%
STIM
RSI 9 days
84.68
RSI 14 days
82.73
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
aa2e59b2fdab0.bFcjtsuSBxWb3lh3PfslEFxphvla1qqU0yg-zEJYOmg.OgBZgv7acny2t24heLxwfwQA77ISg5rc5ENpjQoHVCMbNQ7ms8hmZ82caA
| Date | Price | Volume | Daily volume |
|---|
Monthly variations
Annual change
| 2024 | +31.38% | ||
| 2023 | -20.29% | ||
| 2022 | +47.36% | ||
| 2021 | +41.22% | ||
| 2020 | +1.83% | ||
| 2019 | +75.64% | ||
| 2018 | -44.96% | ||
| 2017 | +199.84% | ||
| 2016 | -57.88% | ||
| 2015 | +7.65% | ||
| 2014 | +68.25% | ||
| 2013 | +254.20% | ||
| 2012 | +110.98% | ||
| 2011 | -14.15% | ||
| 2010 | -41.13% | ||
| 2009 | -24.45% | ||
| 2008 | -15.62% |
- Stock Market
- Equities
- ALNY Stock
- DUL Stock
- Quotes Alnylam Pharmaceuticals, Inc.
